• SENSEX 77,540.83
    3.11 (+0.00%)
  • BANKNIFTY 57,761.95
    266.05 (+0.46%)
  • HDFC Bank
    732.85 1,020.35(%)
  • Welspun Corp
    2,348.30 2,348.30(%)
  • 360 ONE
    1,190.00 906.20(%)
  • Shadowfax Technologies
    259.85 268.55(%)
  • Hyundai Motor I
    2,210.85 1,658.45(%)
  • Netweb Technol.
    5,675.00 5,675.00(%)
  • Dhoot Transmission
    1,523.85 1,523.85(%)
  • KDDL Ltd
    4,065.00 4,150.00(%)
  • N S D L
    839.00 1,382.00(%)
  • Deepak Nitrite
    1,726.00 1,280.40(%)
  • Pine Labs
    156.25 134.75(%)
  • Balrampur Chini
    714.30 393.40(%)
  • Radico Khaitan
    4,613.30 2,504.60(%)
  • Interglobe Aviat
    5,053.75 3,894.80(%)
  • Hindustan Copper
    581.00 759.20(%)
  • Cupid
    287.95 298.95(%)
  • HDFC AMC
    2,596.70 2,206.05(%)
  • Himadri Special
    650.25 420.00(%)
  • Meesho
    204.40 125.70(%)
  • Shiprocket
    136.72 129.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Triochem Products Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 1527.0
  • ISIN : INE331E01013
17.40 0 (1.75%)
  • As on 22 Aug 2026 (EOD)

  • Today’s Low

    17.40

  • Today’s High

    17.40

  • Open

    17.40

  • Perv Close

    17.10

  • 52W Low

    0.00

  • 52W High

    0.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    0.43

  • Div & Yield %

    0.00

  • Book Value(₹)

    842.78

  • Debt-Equity Ratio

    1.75

  • AGM Date

    24-Sep-2015

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    0.43

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    0.25

  • BV (₹)

    842.80

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -5.94

  • NP Var(%)

    -589.0

  • Div%

    0.0

  • CPS (₹)

    -240.40

  • EPS (₹)

    -242.30

  • Traded Value (₹ in Lakhs)

    0.43

  • 52 Week High

    0.00

  • 52 Week Low

    0.00

  • Price BSE

    17.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    0.43

  • P/C Ratio

    -0.10

  • P/E Ratio

    -0.10

  • Price Vs.BV

    -242.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 8.82 13.94
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 8.82 13.94
Other Income 12.03 1.05 1.03 0.28 0.56 0.13
Stock Adjustments 0.00 0.00 0.00 0.00 -0.79 -0.13
Total Income 12.03 1.05 1.03 0.28 8.59 13.94
EXPENDITURE :            
Raw Materials 0.00 0.05 0.00 0.00 5.51 12.48
Power and Fuel Cost 0.52 0.36 0.29 0.29 0.25 0.43
Employee Cost 0.53 0.59 0.47 0.52 0.50 0.67
Other Manufacturing Expenses 0.02 0.03 0.11 0.33 0.26 0.32
Selling and Administration Expenses 0.23 0.15 0.15 0.18 0.14 0.26
Miscellaneous Expenses 0.06 0.03 1.25 0.03 0.04 0.02
Employee Benefit Expenses 0.53 0.59 0.47 0.52 0.50 0.67
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1.36 1.21 2.27 1.34 6.70 14.18
Operating Profit 10.66 -0.17 -1.24 -1.06 1.90 -0.23
Interest 0.10 0.00 0.00 0.00 0.02 0.21
Gross Profit 10.56 -0.17 -1.24 -1.06 1.88 -0.44
Depreciation 0.05 0.08 0.09 0.11 0.12 0.14
Profit Before Tax 10.51 -0.25 -1.33 -1.17 1.76 -0.58
Current Tax 2.14 -0.12 0.12 -0.01 0.33 -0.01
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.40 0.27 -0.44 -0.28 0.11 -0.13
Reported Net Profit 7.97 -0.40 -1.01 -0.89 1.32 -0.45
Extraordinary Items 13.91 0.46 -0.89 0.08 0.00 0.00
Adjusted Net Profit -5.94 -0.86 -0.12 -0.97 1.32 -0.45
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 9.55 9.95 10.14 11.03 9.71 10.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 -0.82 0.00 0.00 0.00
P & L Balance carried down 17.52 9.55 9.95 10.14 11.03 9.71
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 325.33 -16.34 -41.36 -36.13 53.99 -18.24
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 842.78 557.83 596.74 473.36 532.51 478.04
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    68.65%

  • Public Share Holding

    31.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 168,190 68.65 168,190 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 168,190 68.65 168,190 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 36,250 14.80 36,000 4
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 0 0.00 0 0
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,500 1.02 2,000 2
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 38,060 15.53 24,060 44
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 76,810 31.35 62,060 50
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 245,000 100.00 230,250 55

Company Background

Triochem Products LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Triochem Products Ltd
  • BSE Code : 1527.0
  • ISIN : INE331E01013

  • Incorporation Year

    1972

  • Registered Office

    Sambhava Chambers
    4th Floor Sir P M Road, Mumbai,
    Maharashtra-400001

  • Telephone

    91-22-22663150

  • FAX

    91-22-22024657

  • Chairman

  • Managing Director

  • Company Secretary

    Ureca Shirish Shirole

  • Auditor

    Kanu Doshi Associates LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Triochem Products Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Triochem Product 17.40 0.86 0.00 0.05 -4.31
Abbott India 26,245.55 7,217.19 6,929.05 34.54 43.78
Astrazeneca Phar 7,410.50 2,304.07 2,275.58 109.22 27.86
Glaxosmi. Pharma 2,899.60 3,932.76 3,790.20 46.32 58.17
Cipla 1,426.20 20,102.60 18,979.95 37.48 13.88
Novartis India 1,423.40 398.23 356.27 35.94 16.64
Bliss GVS Pharma 582.25 773.53 729.81 54.06 12.51
Amrutanjan Healt 536.60 469.50 451.82 28.74 21.89
Fermenta Biotec. 478.20 474.15 450.25 22.32 18.77
Guj. Themis Bio. 380.90 152.47 150.80 85.21 27.21
Ambalal Sarabhai 45.28 19.52 3.94 83.85 6.77